Excelsior Biopharma Financial Flexibility Index
Excelsior Biopharma financial flexibility index. Excelsior Biopharma (6496) has a Financial Flexibility Index of -0.02x as of June 2026. Free cash flow of NT$-16.33 Million (operating CF NT$-20.04 Million minus capex NT$3.70 Million) represents 0% of total liabilities (NT$728.80 Million). See Excelsior Biopharma free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Excelsior Biopharma (2017–2025)
Financial flexibility index of Excelsior Biopharma from 2017 to 2025. Historical Financial Flexibility Index trend for Excelsior Biopharma across 9 annual periods. Check Excelsior Biopharma (6496) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Excelsior Biopharma Financial Flexibility Index by Year (2017–2025)
Excelsior Biopharma financial flexibility index by year from 2017 to 2025. Year-by-year free cash flow to debt coverage for Excelsior Biopharma. For the full cash flow conversion analysis, see Excelsior Biopharma cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (TWD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.15x | NT$-101.78 Million | NT$-138.72 Million | NT$679.78 Million | ▼ -155.8% |
| 2024 | 0.27x | NT$157.35 Million | NT$-99.80 Million | NT$586.89 Million | ▲ +227.9% |
| 2023 | -0.21x | NT$-99.09 Million | NT$-134.75 Million | NT$472.87 Million | ▼ -901.5% |
| 2022 | 0.03x | NT$13.27 Million | NT$5.49 Million | NT$507.53 Million | ▼ -72.9% |
| 2021 | 0.10x | NT$58.70 Million | NT$55.82 Million | NT$608.90 Million | ▼ -88.8% |
| 2020 | 0.86x | NT$532.43 Million | NT$520.81 Million | NT$617.15 Million | ▲ +241.0% |
| 2019 | -0.61x | NT$-149.36 Million | NT$-169.74 Million | NT$244.06 Million | ▼ -221.5% |
| 2018 | 0.50x | NT$136.46 Million | NT$126.92 Million | NT$270.88 Million | ▼ -53.5% |
| 2017 | 1.08x | NT$367.57 Million | NT$349.47 Million | NT$339.37 Million | — |